The Benefits Of Personalized Medicine

Personalized medicine is currently on the running towards becoming one of the leading advancing fields of health care determined by a person’s individual genetic make-up. It enables an understanding of the molecular framework of the human system so as to augment preventive therapeutic strategies. The move from reactive to preventive health care comes about with the implementation of personalized medicine as an alternative to traditional health care practices.

HC2: With personalized medicine comes many areas of concern, including cost and ethics. It is well known that medical testing of any kind is typically very costly, and personalized medicine is no different. Medical institutions are often slow to adopt new technology and unwilling

The need for new and more effective treatment continues to increase and personalized medicine appears to be the answer to our prayers. With further research personalized medicine could revolutionize pharmaceuticals and to go out on a limb even find a cure for aids and other cancers. But it is too early to have high expectations for a science that has not been deeply explored. It seems that the fantasy of finding a perfect match treatment for each individual has raised support from many institutions including the White House and the FDA. There have been some recent personalized medicine treatments approved by the FDA and this has lead President Obama to bring forward the Precision Medicine Initiative (U.S. Food and Drug Administration), which would give millions in monetary support for research to be conducted on personalized medicine. The issue here is whether

Often, with the discovery of knowledge come difficult questions, thorny ethical issues, and unintended consequences. Armed with this new ability to sequence human genes, science grabbed medicine by the hand and charged into uncharted territory. Could we now “personalize” medicine?

The book The Personalized Medicine Revolution: How Diagnosing and Treating Disease are About to Change Forever is an interesting journey through the evolution of our scientific knowledge and subsequent technologies followed by a final foray into the most current accomplishments in personalized medicine and where it’s going.

In June 2000, the publicly funded Human Genome Project (HGP) and the private firm Celera Genomics Inc. announced that they had completed sequencing the human genome. This unprecedented accomplishment is expected to enable doctors to diagnose, treat and even prevent numerous genetic diseases. As these two entities worked on sequencing the human genome, there was also a separate and less publicized race to patent as many human genes as possible.

   Over the last century, humanity has created an impressive biological technology.  We have crafted an arsenal of vaccines and antibiotics to defend ourselves from the microscopic world of bacteria and viruses.   We have developed the means to diagnose genetic problems, and we are developing means to treat them.  We have developed a huge number of synthetic substances to enhance human performance, and later human behavior.  We have genetically modified our food crops.  We have created human life in test tubes.  We have sequenced the human genome.  We have cloned sheep and cows.  We have begun research on a variety of stem cells with potential to create cellular therapies

Every individuals response to drugs is based on their genetic makeup. Pharmacogenomic allows physicians to treat patients according to their genotypical treatment match. With a better understanding of an individual’s disease through pharmacogenomics, treatments can be mainly focus on patient’s disease and is likely to be effective due to prior testing. This will prevent patient’s from having many medication side effects, advert effect, and drug toxicity. It will help in making a better decision when it comes to drug therapy. Healthcare will be less costive for the patient because physicians will only use drug that works best for a person and avoiding the unnecessary

Josko (2014) asserts that the era of personalized medicine is upon us, and that with the completion of the Human Genome Project, and advances in DNA sequencing techniques and

revolutionizing medicine and treating disease. It is believed that Gene Therapy holds the key to

Then you attack it” (Garreau 28-30). Organizations such as DARPA and CAP strive to make unstoppable human beings. For instance, take the well-developed movie Gattaca which came to theaters in 2010 and was about a man that manipulates his DNA to hide his identity to be a more advanced, genetically engineered, human being. No one is capable of stopping him from becoming a better meaningful species to society. Most Americans strive to build themselves up to become the best they can be. Americans' study the use of DNA manipulation in bodies and cells to help fight off diseases and illnesses such as the common cold or flu. Goldblatt proclaims, “We do not fear the unknown, and we relish exploring the unknowable” (Garreau 19). Americans should be more like this quote and strive to become the best species that has ever existed. DARPA is studying a vaccine that will help in pain management. Such vaccines will make milestones in terms of medicine. If someone is hurt they will feel the first trigger of pain but the pain will soon subside (Garreau 19-28). This pain vaccine will have many benefits to Americans dealing with diseases and to society.

Exploration into the function of each gene discovered will continue well into the 21st century. The knowledge gained from this will lead us to better understand the cause of genetically related diseases. Having the ability to recognize the causation of a disease will shift technology from trial and error treatments to specific drugs designed to treat the gene sequence and protein structure. This is called gene therapy and is the most exciting aspect of the HGP. It gives the

Techniques, like “[plant] cell culture, recombinant DNA [deoxyribonucleic acid] technology and cellular cloning, [would] now provide us with new ways to tap into natural diversity”(Seidler para. 3). To put it another way, biotechnology could provide new medicines. New medicines could eliminate side effect and eradicate repeated visit for injection in treatment for diseases or cancer(Christopher para. 4). Therefore, limiting biotechnology would hinder the process of creating new medicine. Medine would not be the only one affected in the medical field, but in addition, diseases could be

Every living thing is the product of the genes that were passed down from ancestors. Genes make up everything we are. One gets their traits from their parents. Most people live full lives with relatively good health. However, some people inherit mutated genes or faulty genes. This could lead to genetic disorders that could be life threatening. Even today, many genetic disorders still remain incurable, leaving many people without hope. Genetic therapy could be their answer. It is through this research that the cure for genetic disorders can be found. Though some people believe it is unethical or immoral to alter genes, current therapeutics have not been able to save the lives of the patients with these diseases. Genetic therapy

These personal companions are able to monitor every human reaction to physical and emotional stimuli, as well as, how a specific disease process is affecting the different systems of the body, and how medications are systemically treating any disease process. This system will detect disease processes much earlier than is capable at the present time. This information is then transmitted to this global health care network, as previously mentioned, and the data used to better understand disease processes and help to find cures for these diseases. The human genome has also been decoded by computers, for the cost of around one-hundred dollars. With this technology, medical professionals can better understand why some people, and who these people are specifically, are more susceptible to different types of cancer, heart disease, diabetes and so on. These chronic conditions and diseases will be cured and prevented and the larger problem will be mutating viruses and “super bugs”, for which pharmaceutical companies have put very little effort into developing curative or nonresistant medications.